ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2718

Is Smoking Important in Adult IgA Vasculitis?

Alojzija Hočevar1, Ziga Rotar1, Vesna Jurcic2 and Matija Tomšič3, 1Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, 2Institute of Pathology, University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia, 3University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Henoch-Schönlein purpura and vasculitis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Vasculitis Poster III: Other Vasculitis Syndromes

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Nicotine may predispose to kidney injury by increasing the oxidative stress, and there is known association between smoking and the progression of chronic kidney disease, including IgA nephropathy. Currently, there is no information about the influence of smoking on the presentation of IgA vasculitis (IgAV) in adults. The aim of our study was to evaluate the role of smoking on the clinical manifestations of acute adult IgA vasculitis.

Methods: We analyzed medical records of histologically proven, adult IgAV cases, diagnosed between January, 1 2010 and April, 30 2017 at our at our secondary/tertiary rheumatology center. The disease activity was assessed using Birmingham vasculitis activity score-3 (BVAS-3). Renal disease was defined severe in case of nephrotic syndrome or nephritic syndrome with acute renal failure. Gastrointestinal (GI) disease was severe in case of bloody diarrhoea, ileus or bowel perforation. We looked at the potential differences in the clinical manifestations of acute IgAV with regard to smoking habits at the time of IgAV presentation (nonsmokers vs. ever smokers vs. current smokers).

Results: During the 76 month period we identified 207 new IgAV cases (56.5 % males, median (IQR) age 64.6 (44.6; 77.3) years). Skin, GI, renal and joint involvement were present in 207 (generalized purpura above the waist in 102 and necrotic in 98), 68 (severe in 17), 94 (severe in 23), and 87 patients, respectively. 87 patients (42.0%) had a positive history of smoking, and 38 of them were current smokers, smoking daily on average (SD) 13 (± 8) cigarettes (range 1 to 30).

Clinical characteristics of nonsmokers vs. ever vs. current smokers are presented in the Table 1. There were no significant differences regarding the frequency of overall GI tract, renal or joint involvement between the groups. However, current smokers had 4.5 times higher risk of clinically severe renal involvement vs. nonsmokers (95%CI 1.8 – 11.0; p=0.001). Past smokers developed severe renal involvement as frequent as nonsmokers (p= 0.202)

Conclusion: Current smoking was associated with the clinically more severe kidney involvement in adult IgAV. This increased risk disappeared with smoking cessation.

Table 1.

Clinical characteristics

Nonsmokers

(120)

Ever smokers

(87)

Current smokers

(38)

Male gender

44.2

73.6

65.8

Age (years)*

69.2 (41.4;80.6)

62.0 (49.5;74.9)

50.3 (39.6;64.2)

Disease duration (days)*

10 (5;21)

8 (5;14)

9(5;16)

Prior infection (%)

35.8

34.5

44.7

Generalized purpura

48.3

50.6

47.4

Skin necroses (%)

46.7

48.3

52.6

Joint involvement (%)

40.8

43.7

52.6

Arthritis (%)

15.0

18.4

21.1

GI tract involvement (%)

32.5

33.3

39.5

Severe GI tract involvement (%)

7.5

9.2

13.2

Renal involvement (%)

41.7

50.6

57.9

Severe renal involvement (%)

5.8

18.4

26.3

IgA level (g/l)*

3.7 (3.0;4.8)

4.5 (3.1; 5.7)

3.9 (2.9;5.2)

BVAS-3

8 (3;14)

9 (4;16)

12 (5;17)

Legend: * median and IQR; severe GI tract involvement – bloody diarrhea or ileus or surgical intervention; severe renal involvement – acute renal failure or nephrotic syndrome; BVAS-3 – Birmingham vasculitis activity score;


Disclosure: A. Hočevar, None; Z. Rotar, None; V. Jurcic, None; M. Tomšič, None.

To cite this abstract in AMA style:

Hočevar A, Rotar Z, Jurcic V, Tomšič M. Is Smoking Important in Adult IgA Vasculitis? [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/is-smoking-important-in-adult-iga-vasculitis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/is-smoking-important-in-adult-iga-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology